QT
VYGR icon

Quantbot Technologies’s Voyager Therapeutics VYGR Stock Holding History

Quantbot Technologies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500
Closed -$14K – 1953
2024
Q1 		$14K Buy
+1,500
New +$12.7K ﹤0.01% 1437
2021
Q4 		– Sell
-3,649
Closed -$9K – 1962
2021
Q3 		$9K Sell
3,649
-400
-10% -$1.3K ﹤0.01% 1364
2021
Q2 		$16K Sell
4,049
-11,006
-73% -$49.9K ﹤0.01% 1254
2021
Q1 		$70K Buy
+15,055
New +$103K 0.01% 944
2019
Q4 		– Sell
-4,295
Closed -$73K – 1619
2019
Q3 		$73K Buy
+4,295
New +$90.2K 0.01% 898
2018
Q3 		– Sell
-7,095
Closed -$138K – 1576
2018
Q2 		$138K Buy
7,095
+4,549
+179% +$89.9K 0.01% 810
2018
Q1 		$47K Sell
2,546
-1,227
-33% -$26.5K ﹤0.01% 984
2017
Q4 		$62K Buy
+3,773
New +$64.7K 0.01% 945

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Quantbot Technologies's VYGR Position: Q2 2024 in Review

Quantbot Technologies sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 1,500 shares — an estimated $14K sold.

Quantbot Technologies first reported a position in VYGR in Q4 2017 and held it in 8 quarters. The position peaked at $138K in Q2 2018. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Quantbot Technologies reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,500 Voyager Therapeutics shares in Q2 2024, an estimated $14K.
  • Quantbot Technologies first reported a position in Voyager Therapeutics in Q4 2017 and held it in 8 quarters.
  • Quantbot Technologies's Voyager Therapeutics position peaked at $138K in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.